Prognosis Prediction of Diffuse Large B-Cell Lymphoma in $^{18}$F-FDG PET Images Based on Multi-Deep-Learning Models-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prognosis Prediction of Diffuse Large B-Cell Lymphoma in $^{18}$F-FDG PET Images Based on Multi-Deep-Learning Models

Published:2024-07 Issue:7 Volume:28 Page:4010-4023
ISSN:2168-2194
Container-title:IEEE Journal of Biomedical and Health Informatics
language:
Short-container-title:IEEE J. Biomed. Health Inform.

Author:

Qian Chunjun¹^ORCID,Jiang Chong²,Xie Kai³^ORCID,Ding Chongyang⁴,Teng Yue²,Sun Jiawei³^ORCID,Gao Liugang³^ORCID,Zhou Zhengyang²^ORCID,Ni Xinye³^ORCID

Affiliation:

1. Hertfordshire College, Changzhou Institute of Technology, Changzhou, China

2. Department of Nuclear Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Nanjing University Medical School, Nanjing, China

3. Changzhou NO.2 People's Hospital, Nanjing Medical University, Changhzou, China

4. Department of Nuclear Medicine, First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China

Funder

National Natural Science Foundation of China

General Program of Jiangsu Provincial Health Commission

Natural Science Research Project of Colleges and Universities in Jiangsu Province

Changzhou Leading Innovative Talents Introduction and Cultivation Project

Changzhou Institute of Technology

Publisher

Institute of Electrical and Electronics Engineers (IEEE)

Link

http://xplorestaging.ieee.org/ielx7/6221020/10582272/10504915.pdf?arnumber=10504915

Reference73 articles.

1. Diffuse large B‐cell lymphoma: 2019 update on diagnosis, risk stratification, and treatment

2. Genetic and epigenetic determinants of diffuse large B-cell lymphoma

3. Rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in diffuse large B-cell lymphoma

4. Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA Study Group

5. Prognosis of patients with diffuse large B cell lymphoma not reaching complete response or relapsing after frontline chemotherapy or immunochemotherapy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3